Opko Health OPK
NASDAQ OPK
$1.72 +0.02 (+1.48%)
As of: Sep 22, 2026 · 10:53 AM EDT

Opko Health (OPK) Gains from Investment Securities (2012 - 2023)

Opko Health's (OPK) quarterly Gains from Investment Securities came in at -$13000.0 in Q4 2023, up 97.93% on a YoY basis from -$6568.1 in Q4 2022, and up 98.84% quarter-over-quarter from -$1.1 million in Q3 2023.

Analysis

Opko Health (OPK) Gains from Investment Securities (2012 - 2023) Analysis & Trends

Opko Health (OPK) has reported Gains from Investment Securities for 12 consecutive years, with -$13000.0 the latest figure, recorded in Q4 2023.

  • For the quarter ending Q4 2023, Gains from Investment Securities rose 97.93% year-over-year to -$13000.0; the trailing twelve-month figure through Sep 2024 stood at -$13000.0 (up 99.21% YoY), and the FY2023 full-year result was -$1.0 million, up 21.04% from the prior year.
  • Gains from Investment Securities advanced to -$13000.0 in Q4 2023 per OPK's latest filing, from -$1.1 million in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $4.8 million in Q1 2019 and bottomed at -$14.8 million in Q4 2019.
  • Historically, Gains from Investment Securities has averaged -$1.1 million across 5 years, with a median of -$322000.0 in 2021.
  • The widest YoY moves for Gains from Investment Securities: up 269.9% in 2022, down 326.53% in 2022.
  • Over 5 years, Gains from Investment Securities stood at -$14.8 million in 2019, then surged by 63.98% to -$5.3 million in 2020, then soared by 97.24% to -$147000.0 in 2021, then slumped by 326.53% to -$627000.0 in 2022, then jumped by 97.93% to -$13000.0 in 2023.
  • According to Business Quant data, Gains from Investment Securities over the past three periods registered -$13000.0, -$1.1 million, and -$34000.0 for Q4 2023, Q3 2023, and Q2 2023 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 650.65 Bn 629.89 Bn 17.26 Bn
2 AbbVie 466.34 Bn 459.82 Bn 12.70 Bn
3 Merck 362.11 Bn 355.02 Bn 12.21 Bn
4 Novartis Ag 267.81 Bn 260.52 Bn 11.24 Bn
5 Pfizer 157.31 Bn 145.91 Bn 10.94 Bn
6 Bristol Myers Squibb 128.75 Bn 117.69 Bn 9.25 Bn
7 Sanofi 51.80 Bn 44.84 Bn 10.79 Bn
8 Revolution Medicines 40.91 Bn 40.91 Bn -
9 BeOne Medicines 39.65 Bn 34.55 Bn 1.53 Bn
10 Opko Health 1.25 Bn 945.61 Mn 80.02 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 -13,000.00
Sep 30, 2023 -1.13 Mn
Jun 30, 2023 -34,000.00
Mar 31, 2023 136,000.00
Dec 31, 2022 -627,000.00
Sep 30, 2022 -754,000.00
Jun 30, 2022 175,000.00
Mar 31, 2022 -106,000.00
Dec 31, 2021 -147,000.00
Sep 30, 2021 -497,000.00
Jun 30, 2021 -103,000.00
Mar 31, 2021 -957,000.00
Dec 31, 2020 -5.32 Mn
Sep 30, 2020 1.08 Mn
Jun 30, 2020 1.11 Mn
Mar 31, 2020 -860,000.00
Dec 31, 2019 -14.78 Mn
Sep 30, 2019 -1.11 Mn
Jun 30, 2019 -3.78 Mn
Mar 31, 2019 4.81 Mn
API Access

Opko Health Gains from Investment Securities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-investment-securities&ticker=OPK&period=max&api_key=YOUR_API_KEY